115例湿疹婴儿体格生长情况调查

发布时间：2018-07-29 06:03

【摘要】：目的了解正规外用糖皮质激素治疗的湿疹患儿体格生长情况。方法纳入初诊为湿疹的足月婴儿115例,正规外用糖皮质激素治疗;定期评估患儿湿疹情况并进行生长监测和评估。结果 115例患儿出生时以及接受治疗6个月时的按年龄体质量Z评分(WAZ)和按年龄身长Z评分(LAZ)均高于世界卫生组织(WHO)儿童生长标准;而初诊时、接受治疗3个月时的LAZ均低于WHO儿童生长标准。湿疹患儿的体质量、身长,从出生至初诊时的生长速度均低于WHO生长标准,而接受治疗后3至6个月时的生长速度均高于WHO儿童生长标准。出生至初诊、初诊至接受治疗3个月,以及治疗后3至6个月,三个时间段比较,WAZ和LAZ增长值的差异均有统计学意义(P均0.001)。结论湿疹患儿在患病初期,症状未控制时体格生长呈减速生长,治疗后则呈现加速。提示正规外用糖皮质激素治疗湿疹对患儿体格生长无不良影响,且随疾病控制有利于婴儿体格生长恢复。
[Abstract]:Objective to investigate the physical growth of children with eczema treated with regular external glucocorticoid therapy. Methods 115 infants with eczema were treated with glucocorticoid, and their eczema status was evaluated regularly. Results at birth and 6 months after treatment, (WAZ) and Z score (LAZ) by age were higher than those of (WHO) children by WHO, but at first visit, there was no significant difference between them. LAZ at 3 months of treatment was lower than that of WHO children. The body weight, body length and growth rate of children with eczema from birth to first visit were lower than that of WHO, while the growth rate of children with eczema at 3 to 6 months after treatment was higher than that of children with WHO. From birth to first visit, from first visit to receiving treatment for 3 months, and from 3 to 6 months after treatment, there were significant differences in the increase of WAZ and LAZ between the three periods (all P 0.001). Conclusion in the early stage of eczema, the physical growth of children with eczema was decelerated when the symptoms were not controlled, and accelerated after treatment. It is suggested that the treatment of eczema with regular external glucocorticoid has no adverse effect on the physical growth of children, and it is beneficial to the recovery of physical growth with disease control.
【作者单位】：重庆医科大学附属儿童医院;
【分类号】：R758.23

【相似文献】